Iron Deficiency in COPD Associates with Increased Pulmonary Artery Pressure Estimated by Echocardiography.

[1]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.

[2]  J. Logomarsino,et al.  Anemia in Chronic Obstructive Pulmonary Disease and the Potential Role of Iron Deficiency , 2016, COPD.

[3]  N. Westerhof,et al.  Intravenous Iron Therapy in Patients with Idiopathic Pulmonary Arterial Hypertension and Iron Deficiency , 2015, Pulmonary circulation.

[4]  P. Robbins,et al.  A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease , 2015, BMJ Open.

[5]  S. Bonnet,et al.  The iron paradigm of pulmonary arterial hypertension: Popeye knows best. , 2015, Circulation research.

[6]  Lan Zhao,et al.  Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat. , 2015, Circulation research.

[7]  K. Iversen,et al.  Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease , 2013, BMC Cardiovascular Disorders.

[8]  I. Cavill,et al.  Guideline for the laboratory diagnosis of functional iron deficiency , 2013, British journal of haematology.

[9]  P. Ponikowski,et al.  Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives , 2012, European heart journal.

[10]  N. Hill,et al.  Iron chelation inhibits the development of pulmonary vascular remodeling. , 2012, Free radical biology & medicine.

[11]  Thomas G. Smith,et al.  Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. , 2009, JAMA.

[12]  R. Naeije,et al.  Pulmonary hypertension in COPD , 2008, European Respiratory Journal.

[13]  Thomas G. Smith,et al.  The increase in pulmonary arterial pressure caused by hypoxia depends on iron status , 2008, The Journal of physiology.

[14]  P. Robbins,et al.  Desferrioxamine elevates pulmonary vascular resistance in humans: potential for involvement of HIF-1. , 2002, Journal of applied physiology.